Nuvalent, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Nuvalent, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($122.44M) | Oct 30, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($99.65M) | Aug 7, 2025 |
| Q3 | 2025 | Jun 30, 2025 | ($99.65M) | Oct 30, 2025 |
| Q2 | 2025 | Mar 31, 2025 | ($84.58M) | Aug 7, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($84.58M) | May 8, 2025 |
| Q3 | 2025 | Mar 31, 2025 | ($84.58M) | Oct 30, 2025 |
| Q2 | 2025 | Dec 31, 2024 | ($260.80M) | Aug 7, 2025 |
| Q3 | 2025 | Dec 31, 2024 | ($260.80M) | Oct 30, 2025 |
| Q1 | 2025 | Dec 31, 2024 | ($260.80M) | May 8, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($84.35M) | Oct 30, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($57.17M) | Aug 7, 2025 |
| Q3 | 2025 | Jun 30, 2024 | ($57.17M) | Oct 30, 2025 |
| Q3 | 2025 | Mar 31, 2024 | ($44.48M) | Oct 30, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($44.48M) | May 8, 2025 |
| Q2 | 2025 | Mar 31, 2024 | ($44.48M) | Aug 7, 2025 |
| Q3 | 2024 | Dec 31, 2023 | ($126.20M) | Nov 12, 2024 |
| Q1 | 2024 | Dec 31, 2023 | $126.20M | May 9, 2024 |
| Q2 | 2024 | Dec 31, 2023 | ($126.20M) | Aug 8, 2024 |
| Q3 | 2024 | Sep 30, 2023 | ($33.65M) | Nov 12, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($29.09M) | Aug 8, 2024 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2025 | Sep 30, 2025 | ($112.70M) | Oct 30, 2025 |
| Q2 | 2025 | Jun 30, 2025 | ($104.57M) | Aug 7, 2025 |
| Q1 | 2025 | Mar 31, 2025 | ($94.81M) | May 8, 2025 |
| Q3 | 2025 | Sep 30, 2024 | ($76.33M) | Oct 30, 2025 |
| Q2 | 2025 | Jun 30, 2024 | ($65.15M) | Aug 7, 2025 |
| Q1 | 2025 | Mar 31, 2024 | ($52.59M) | May 8, 2025 |
| Q3 | 2024 | Sep 30, 2023 | ($38.78M) | Nov 12, 2024 |
| Q2 | 2024 | Jun 30, 2023 | ($34.06M) | Aug 8, 2024 |
| Q1 | 2024 | Mar 31, 2023 | ($30.21M) | May 9, 2024 |
| Q3 | 2023 | Sep 30, 2022 | ($20.39M) | Nov 14, 2023 |
| Q2 | 2023 | Jun 30, 2022 | ($18.73M) | Aug 10, 2023 |
| Q1 | 2023 | Mar 31, 2022 | ($17.69M) | May 11, 2023 |
| Q3 | 2022 | Sep 30, 2021 | ($12.43M) | Nov 10, 2022 |
| Q2 | 2022 | Jun 30, 2021 | ($9.85M) | Aug 10, 2022 |
| Q1 | 2022 | Mar 31, 2021 | ($6.16M) | May 12, 2022 |
| Q3 | 2021 | Sep 30, 2020 | ($4.04M) | Nov 10, 2021 |
| Q2 | 2021 | Jun 30, 2020 | ($4.01M) | Sep 8, 2021 |